Literature DB >> 32282291

Degradable Poly(Methyl Methacrylate)-co-Methacrylic Acid Nanoparticles for Controlled Delivery of Growth Factors for Bone Regeneration.

Tinke-Marie De Witte1,2, Angela M Wagner3,4, Lidy E Fratila-Apachitei2, Amir A Zadpoor2, Nicholas A Peppas1,3,4,5,6,7.   

Abstract

Bone tissue engineering strategies have been developed to address the limitations of the current gold standard treatment options for bone-related disorders. These systems consist of an engineered scaffold that mimics the extracellular matrix and provides an architecture to guide the natural bone regeneration process, and incorporated growth factors that enhance cell recruitment and ingress into the scaffold and promote the osteogenic differentiation of stem cells and angiogenesis. In particular, the osteogenic growth factor bone morphogenetic protein 2 (BMP-2) has been widely studied as a potent agent to improve bone regeneration. A key challenge in growth factor delivery is that the growth factors must reach their target sites without losing bioactivity and remain in the location for an extended period to effectively aid in the formation of new bone. Protein incorporation into nanoparticles can both protect protein bioactivity and enable its sustained release. In this study, a poly(methyl methacrylate-co-methacrylic acid) nanoparticle-based system was synthesized incorporating a custom poly(ethylene glycol) dimethacrylate crosslinker. It was demonstrated that the nanoparticle degradation rate can be controlled by tuning the number of hydrolytically degradable ester units along the crosslinker. We also showed that the nanoparticles had high affinity for a model protein for BMP-2, and optimal conditions for maximum protein loading efficiency were elucidated. Ultimately, the proposed system and its high degree of tunability can be applied to a wide range of growth factors and tissue engineering applications. Impact Statement In this study, we developed a novel method of synthesizing nanoparticles with tunable degradation rates through the incorporation of a custom synthesized, hydrolytically degradable crosslinker. In addition, we demonstrated the affinity of the synthesized nanoparticles for a model protein for bone morphogenetic protein 2 (BMP-2). The tunability of these nanoparticles can be used to develop complex tissue engineering systems, for example, for the delivery of multiple growth factors involved at different stages of the bone regeneration process.

Entities:  

Keywords:  bone regeneration; controlled release; growth factor delivery; nanocarriers; tunable degradation

Year:  2020        PMID: 32282291      PMCID: PMC7757707          DOI: 10.1089/ten.tea.2020.0010

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  32 in total

1.  Polybasic Nanomatrices Prepared By UV-initiated Photopolymerization.

Authors:  Omar Z Fisher; Nicholas A Peppas
Journal:  Macromolecules       Date:  2009-05-12       Impact factor: 5.985

Review 2.  Biomimetic supramolecular designs for the controlled release of growth factors in bone regeneration.

Authors:  Helena S Azevedo; Iva Pashkuleva
Journal:  Adv Drug Deliv Rev       Date:  2015-08-29       Impact factor: 15.470

Review 3.  Importance of dual delivery systems for bone tissue engineering.

Authors:  Mehdi Farokhi; Fatemeh Mottaghitalab; Mohammad Ali Shokrgozar; Keng-Liang Ou; Chuanbin Mao; Hossein Hosseinkhani
Journal:  J Control Release       Date:  2016-01-21       Impact factor: 9.776

4.  Free radical scavenging and antioxidant effects of lactate ion: an in vitro study.

Authors:  C Groussard; I Morel; M Chevanne; M Monnier; J Cillard; A Delamarche
Journal:  J Appl Physiol (1985)       Date:  2000-07

5.  Molecular recognition with soft biomaterials.

Authors:  John R Clegg; Nicholas A Peppas
Journal:  Soft Matter       Date:  2020-01-14       Impact factor: 3.679

Review 6.  Recent advances in bone tissue engineering scaffolds.

Authors:  Susmita Bose; Mangal Roy; Amit Bandyopadhyay
Journal:  Trends Biotechnol       Date:  2012-08-30       Impact factor: 19.536

7.  Determination of the in vivo degradation mechanism of PEGDA hydrogels.

Authors:  M B Browning; S N Cereceres; P T Luong; E M Cosgriff-Hernandez
Journal:  J Biomed Mater Res A       Date:  2014-02-13       Impact factor: 4.396

8.  Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix.

Authors:  Dror Ben-David; Samer Srouji; Keren Shapira-Schweitzer; Olga Kossover; Eran Ivanir; Gisela Kuhn; Ralph Müller; Dror Seliktar; Erella Livne
Journal:  Biomaterials       Date:  2013-01-31       Impact factor: 12.479

9.  Impact of lactic acid on cell proliferation and free radical-induced cell death in monolayer cultures of neural precursor cells.

Authors:  Kyle J Lampe; Rachael M Namba; Tyler R Silverman; Kimberly B Bjugstad; Melissa J Mahoney
Journal:  Biotechnol Bioeng       Date:  2009-08-15       Impact factor: 4.530

Review 10.  A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).

Authors:  William F McKay; Steven M Peckham; Jeffrey M Badura
Journal:  Int Orthop       Date:  2007-07-17       Impact factor: 3.075

View more
  1 in total

Review 1.  Broad-Spectrum Theranostics and Biomedical Application of Functionalized Nanomaterials.

Authors:  Meshal Alshamrani
Journal:  Polymers (Basel)       Date:  2022-03-17       Impact factor: 4.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.